Global Irritable Bowel Syndrome (IBS) Supply, Demand and Key Producers, 2026-2032
The global Irritable Bowel Syndrome (IBS) market size is expected to reach $ 18820 million by 2032, rising at a market growth of 14.6% CAGR during the forecast period (2026-2032).
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.
This report studies the global Irritable Bowel Syndrome (IBS) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Irritable Bowel Syndrome (IBS), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Irritable Bowel Syndrome (IBS) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Irritable Bowel Syndrome (IBS) total market, 2021-2032, (USD Million)
Global Irritable Bowel Syndrome (IBS) total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Irritable Bowel Syndrome (IBS) total market, key domestic companies, and share, (USD Million)
Global Irritable Bowel Syndrome (IBS) revenue by player, revenue and market share 2021-2026, (USD Million)
Global Irritable Bowel Syndrome (IBS) total market by Type, CAGR, 2021-2032, (USD Million)
Global Irritable Bowel Syndrome (IBS) total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Irritable Bowel Syndrome (IBS) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bausch Health, Allergan, Takeda, Sucampo Pharmaceuticals (Mallinckrodt), Sebela Pharmaceuticals Inc, Astellas Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Irritable Bowel Syndrome (IBS) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Irritable Bowel Syndrome (IBS) Market, By Region:
1. How big is the global Irritable Bowel Syndrome (IBS) market?
2. What is the demand of the global Irritable Bowel Syndrome (IBS) market?
3. What is the year over year growth of the global Irritable Bowel Syndrome (IBS) market?
4. What is the total value of the global Irritable Bowel Syndrome (IBS) market?
5. Who are the Major Players in the global Irritable Bowel Syndrome (IBS) market?
6. What are the growth factors driving the market demand?
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.
This report studies the global Irritable Bowel Syndrome (IBS) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Irritable Bowel Syndrome (IBS), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Irritable Bowel Syndrome (IBS) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Irritable Bowel Syndrome (IBS) total market, 2021-2032, (USD Million)
Global Irritable Bowel Syndrome (IBS) total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Irritable Bowel Syndrome (IBS) total market, key domestic companies, and share, (USD Million)
Global Irritable Bowel Syndrome (IBS) revenue by player, revenue and market share 2021-2026, (USD Million)
Global Irritable Bowel Syndrome (IBS) total market by Type, CAGR, 2021-2032, (USD Million)
Global Irritable Bowel Syndrome (IBS) total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Irritable Bowel Syndrome (IBS) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bausch Health, Allergan, Takeda, Sucampo Pharmaceuticals (Mallinckrodt), Sebela Pharmaceuticals Inc, Astellas Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Irritable Bowel Syndrome (IBS) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Irritable Bowel Syndrome (IBS) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- IBS-D Drug
- IBS-C Drug
- Others
- Women
- Men
- Bausch Health
- Allergan
- Takeda
- Sucampo Pharmaceuticals (Mallinckrodt)
- Sebela Pharmaceuticals Inc
- Astellas Pharmaceuticals
1. How big is the global Irritable Bowel Syndrome (IBS) market?
2. What is the demand of the global Irritable Bowel Syndrome (IBS) market?
3. What is the year over year growth of the global Irritable Bowel Syndrome (IBS) market?
4. What is the total value of the global Irritable Bowel Syndrome (IBS) market?
5. Who are the Major Players in the global Irritable Bowel Syndrome (IBS) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Irritable Bowel Syndrome (IBS) Introduction
1.2 World Irritable Bowel Syndrome (IBS) Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Irritable Bowel Syndrome (IBS) Total Market by Region (by Headquarter Location)
1.3.1 World Irritable Bowel Syndrome (IBS) Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.3.3 China Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.3.4 Europe Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.3.5 Japan Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.3.6 South Korea Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.3.7 ASEAN Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.3.8 India Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Irritable Bowel Syndrome (IBS) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.2 World Irritable Bowel Syndrome (IBS) Consumption Value by Region
2.2.1 World Irritable Bowel Syndrome (IBS) Consumption Value by Region (2021-2026)
2.2.2 World Irritable Bowel Syndrome (IBS) Consumption Value Forecast by Region (2027-2032)
2.3 United States Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.4 China Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.5 Europe Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.6 Japan Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.7 South Korea Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.8 ASEAN Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.9 India Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
3 WORLD IRRITABLE BOWEL SYNDROME (IBS) COMPANIES COMPETITIVE ANALYSIS
3.1 World Irritable Bowel Syndrome (IBS) Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Irritable Bowel Syndrome (IBS) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Irritable Bowel Syndrome (IBS) in 2025
3.2.3 Global Concentration Ratios (CR8) for Irritable Bowel Syndrome (IBS) in 2025
3.3 Irritable Bowel Syndrome (IBS) Company Evaluation Quadrant
3.4 Irritable Bowel Syndrome (IBS) Market: Overall Company Footprint Analysis
3.4.1 Irritable Bowel Syndrome (IBS) Market: Region Footprint
3.4.2 Irritable Bowel Syndrome (IBS) Market: Company Product Type Footprint
3.4.3 Irritable Bowel Syndrome (IBS) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Irritable Bowel Syndrome (IBS) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Irritable Bowel Syndrome (IBS) Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Irritable Bowel Syndrome (IBS) Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Irritable Bowel Syndrome (IBS) Consumption Value Comparison
4.2.1 United States VS China: Irritable Bowel Syndrome (IBS) Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Irritable Bowel Syndrome (IBS) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Irritable Bowel Syndrome (IBS) Companies and Market Share, 2021-2026
4.3.1 United States Based Irritable Bowel Syndrome (IBS) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Irritable Bowel Syndrome (IBS) Revenue, (2021-2026)
4.4 China Based Companies Irritable Bowel Syndrome (IBS) Revenue and Market Share, 2021-2026
4.4.1 China Based Irritable Bowel Syndrome (IBS) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Irritable Bowel Syndrome (IBS) Revenue, (2021-2026)
4.5 Rest of World Based Irritable Bowel Syndrome (IBS) Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Irritable Bowel Syndrome (IBS) Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Irritable Bowel Syndrome (IBS) Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Irritable Bowel Syndrome (IBS) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 IBS-D Drug
5.2.2 IBS-C Drug
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026)
5.3.2 World Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032)
5.3.3 World Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Irritable Bowel Syndrome (IBS) Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Women
6.2.2 Men
6.3 Market Segment by Application
6.3.1 World Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026)
6.3.2 World Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032)
6.3.3 World Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Bausch Health
7.1.1 Bausch Health Details
7.1.2 Bausch Health Major Business
7.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Product and Services
7.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Bausch Health Recent Developments/Updates
7.1.6 Bausch Health Competitive Strengths & Weaknesses
7.2 Allergan
7.2.1 Allergan Details
7.2.2 Allergan Major Business
7.2.3 Allergan Irritable Bowel Syndrome (IBS) Product and Services
7.2.4 Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Allergan Recent Developments/Updates
7.2.6 Allergan Competitive Strengths & Weaknesses
7.3 Takeda
7.3.1 Takeda Details
7.3.2 Takeda Major Business
7.3.3 Takeda Irritable Bowel Syndrome (IBS) Product and Services
7.3.4 Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Takeda Recent Developments/Updates
7.3.6 Takeda Competitive Strengths & Weaknesses
7.4 Sucampo Pharmaceuticals (Mallinckrodt)
7.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Details
7.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Major Business
7.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product and Services
7.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments/Updates
7.4.6 Sucampo Pharmaceuticals (Mallinckrodt) Competitive Strengths & Weaknesses
7.5 Sebela Pharmaceuticals Inc
7.5.1 Sebela Pharmaceuticals Inc Details
7.5.2 Sebela Pharmaceuticals Inc Major Business
7.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product and Services
7.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Sebela Pharmaceuticals Inc Recent Developments/Updates
7.5.6 Sebela Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.6 Astellas Pharmaceuticals
7.6.1 Astellas Pharmaceuticals Details
7.6.2 Astellas Pharmaceuticals Major Business
7.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Services
7.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Astellas Pharmaceuticals Recent Developments/Updates
7.6.6 Astellas Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Irritable Bowel Syndrome (IBS) Industry Chain
8.2 Irritable Bowel Syndrome (IBS) Upstream Analysis
8.3 Irritable Bowel Syndrome (IBS) Midstream Analysis
8.4 Irritable Bowel Syndrome (IBS) Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Irritable Bowel Syndrome (IBS) Introduction
1.2 World Irritable Bowel Syndrome (IBS) Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Irritable Bowel Syndrome (IBS) Total Market by Region (by Headquarter Location)
1.3.1 World Irritable Bowel Syndrome (IBS) Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.3.3 China Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.3.4 Europe Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.3.5 Japan Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.3.6 South Korea Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.3.7 ASEAN Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.3.8 India Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Irritable Bowel Syndrome (IBS) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.2 World Irritable Bowel Syndrome (IBS) Consumption Value by Region
2.2.1 World Irritable Bowel Syndrome (IBS) Consumption Value by Region (2021-2026)
2.2.2 World Irritable Bowel Syndrome (IBS) Consumption Value Forecast by Region (2027-2032)
2.3 United States Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.4 China Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.5 Europe Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.6 Japan Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.7 South Korea Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.8 ASEAN Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
2.9 India Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032)
3 WORLD IRRITABLE BOWEL SYNDROME (IBS) COMPANIES COMPETITIVE ANALYSIS
3.1 World Irritable Bowel Syndrome (IBS) Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Irritable Bowel Syndrome (IBS) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Irritable Bowel Syndrome (IBS) in 2025
3.2.3 Global Concentration Ratios (CR8) for Irritable Bowel Syndrome (IBS) in 2025
3.3 Irritable Bowel Syndrome (IBS) Company Evaluation Quadrant
3.4 Irritable Bowel Syndrome (IBS) Market: Overall Company Footprint Analysis
3.4.1 Irritable Bowel Syndrome (IBS) Market: Region Footprint
3.4.2 Irritable Bowel Syndrome (IBS) Market: Company Product Type Footprint
3.4.3 Irritable Bowel Syndrome (IBS) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Irritable Bowel Syndrome (IBS) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Irritable Bowel Syndrome (IBS) Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Irritable Bowel Syndrome (IBS) Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Irritable Bowel Syndrome (IBS) Consumption Value Comparison
4.2.1 United States VS China: Irritable Bowel Syndrome (IBS) Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Irritable Bowel Syndrome (IBS) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Irritable Bowel Syndrome (IBS) Companies and Market Share, 2021-2026
4.3.1 United States Based Irritable Bowel Syndrome (IBS) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Irritable Bowel Syndrome (IBS) Revenue, (2021-2026)
4.4 China Based Companies Irritable Bowel Syndrome (IBS) Revenue and Market Share, 2021-2026
4.4.1 China Based Irritable Bowel Syndrome (IBS) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Irritable Bowel Syndrome (IBS) Revenue, (2021-2026)
4.5 Rest of World Based Irritable Bowel Syndrome (IBS) Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Irritable Bowel Syndrome (IBS) Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Irritable Bowel Syndrome (IBS) Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Irritable Bowel Syndrome (IBS) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 IBS-D Drug
5.2.2 IBS-C Drug
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026)
5.3.2 World Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032)
5.3.3 World Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Irritable Bowel Syndrome (IBS) Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Women
6.2.2 Men
6.3 Market Segment by Application
6.3.1 World Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026)
6.3.2 World Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032)
6.3.3 World Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Bausch Health
7.1.1 Bausch Health Details
7.1.2 Bausch Health Major Business
7.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Product and Services
7.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Bausch Health Recent Developments/Updates
7.1.6 Bausch Health Competitive Strengths & Weaknesses
7.2 Allergan
7.2.1 Allergan Details
7.2.2 Allergan Major Business
7.2.3 Allergan Irritable Bowel Syndrome (IBS) Product and Services
7.2.4 Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Allergan Recent Developments/Updates
7.2.6 Allergan Competitive Strengths & Weaknesses
7.3 Takeda
7.3.1 Takeda Details
7.3.2 Takeda Major Business
7.3.3 Takeda Irritable Bowel Syndrome (IBS) Product and Services
7.3.4 Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Takeda Recent Developments/Updates
7.3.6 Takeda Competitive Strengths & Weaknesses
7.4 Sucampo Pharmaceuticals (Mallinckrodt)
7.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Details
7.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Major Business
7.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product and Services
7.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments/Updates
7.4.6 Sucampo Pharmaceuticals (Mallinckrodt) Competitive Strengths & Weaknesses
7.5 Sebela Pharmaceuticals Inc
7.5.1 Sebela Pharmaceuticals Inc Details
7.5.2 Sebela Pharmaceuticals Inc Major Business
7.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product and Services
7.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Sebela Pharmaceuticals Inc Recent Developments/Updates
7.5.6 Sebela Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.6 Astellas Pharmaceuticals
7.6.1 Astellas Pharmaceuticals Details
7.6.2 Astellas Pharmaceuticals Major Business
7.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Services
7.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Astellas Pharmaceuticals Recent Developments/Updates
7.6.6 Astellas Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Irritable Bowel Syndrome (IBS) Industry Chain
8.2 Irritable Bowel Syndrome (IBS) Upstream Analysis
8.3 Irritable Bowel Syndrome (IBS) Midstream Analysis
8.4 Irritable Bowel Syndrome (IBS) Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Irritable Bowel Syndrome (IBS) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Irritable Bowel Syndrome (IBS) Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Irritable Bowel Syndrome (IBS) Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Irritable Bowel Syndrome (IBS) Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Irritable Bowel Syndrome (IBS) Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Irritable Bowel Syndrome (IBS) Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Irritable Bowel Syndrome (IBS) Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Irritable Bowel Syndrome (IBS) Players in 2025
Table 12. World Irritable Bowel Syndrome (IBS) Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Irritable Bowel Syndrome (IBS) Company Evaluation Quadrant
Table 14. Head Office of Key Irritable Bowel Syndrome (IBS) Players
Table 15. Irritable Bowel Syndrome (IBS) Market: Company Product Type Footprint
Table 16. Irritable Bowel Syndrome (IBS) Market: Company Product Application Footprint
Table 17. Irritable Bowel Syndrome (IBS) Mergers & Acquisitions Activity
Table 18. United States VS China Irritable Bowel Syndrome (IBS) Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Irritable Bowel Syndrome (IBS) Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Irritable Bowel Syndrome (IBS) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Irritable Bowel Syndrome (IBS) Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Irritable Bowel Syndrome (IBS) Revenue Market Share (2021-2026)
Table 23. China Based Irritable Bowel Syndrome (IBS) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Irritable Bowel Syndrome (IBS) Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Irritable Bowel Syndrome (IBS) Revenue Market Share (2021-2026)
Table 26. Rest of World Based Irritable Bowel Syndrome (IBS) Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Irritable Bowel Syndrome (IBS) Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Irritable Bowel Syndrome (IBS) Revenue Market Share (2021-2026)
Table 29. World Irritable Bowel Syndrome (IBS) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Irritable Bowel Syndrome (IBS) Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032) & (USD Million)
Table 32. World Irritable Bowel Syndrome (IBS) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026) & (USD Million)
Table 34. World Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032) & (USD Million)
Table 35. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 36. Bausch Health Major Business
Table 37. Bausch Health Irritable Bowel Syndrome (IBS) Product and Services
Table 38. Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Bausch Health Recent Developments/Updates
Table 40. Bausch Health Competitive Strengths & Weaknesses
Table 41. Allergan Basic Information, Manufacturing Base and Competitors
Table 42. Allergan Major Business
Table 43. Allergan Irritable Bowel Syndrome (IBS) Product and Services
Table 44. Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Allergan Recent Developments/Updates
Table 46. Allergan Competitive Strengths & Weaknesses
Table 47. Takeda Basic Information, Manufacturing Base and Competitors
Table 48. Takeda Major Business
Table 49. Takeda Irritable Bowel Syndrome (IBS) Product and Services
Table 50. Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Takeda Recent Developments/Updates
Table 52. Takeda Competitive Strengths & Weaknesses
Table 53. Sucampo Pharmaceuticals (Mallinckrodt) Basic Information, Manufacturing Base and Competitors
Table 54. Sucampo Pharmaceuticals (Mallinckrodt) Major Business
Table 55. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product and Services
Table 56. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments/Updates
Table 58. Sucampo Pharmaceuticals (Mallinckrodt) Competitive Strengths & Weaknesses
Table 59. Sebela Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 60. Sebela Pharmaceuticals Inc Major Business
Table 61. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product and Services
Table 62. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Sebela Pharmaceuticals Inc Recent Developments/Updates
Table 64. Sebela Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 65. Astellas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 66. Astellas Pharmaceuticals Major Business
Table 67. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Services
Table 68. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Astellas Pharmaceuticals Recent Developments/Updates
Table 70. Astellas Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. Global Key Players of Irritable Bowel Syndrome (IBS) Upstream (Raw Materials)
Table 72. Global Irritable Bowel Syndrome (IBS) Typical Customers
Table 1. World Irritable Bowel Syndrome (IBS) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Irritable Bowel Syndrome (IBS) Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Irritable Bowel Syndrome (IBS) Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Irritable Bowel Syndrome (IBS) Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Irritable Bowel Syndrome (IBS) Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Irritable Bowel Syndrome (IBS) Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Irritable Bowel Syndrome (IBS) Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Irritable Bowel Syndrome (IBS) Players in 2025
Table 12. World Irritable Bowel Syndrome (IBS) Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Irritable Bowel Syndrome (IBS) Company Evaluation Quadrant
Table 14. Head Office of Key Irritable Bowel Syndrome (IBS) Players
Table 15. Irritable Bowel Syndrome (IBS) Market: Company Product Type Footprint
Table 16. Irritable Bowel Syndrome (IBS) Market: Company Product Application Footprint
Table 17. Irritable Bowel Syndrome (IBS) Mergers & Acquisitions Activity
Table 18. United States VS China Irritable Bowel Syndrome (IBS) Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Irritable Bowel Syndrome (IBS) Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Irritable Bowel Syndrome (IBS) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Irritable Bowel Syndrome (IBS) Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Irritable Bowel Syndrome (IBS) Revenue Market Share (2021-2026)
Table 23. China Based Irritable Bowel Syndrome (IBS) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Irritable Bowel Syndrome (IBS) Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Irritable Bowel Syndrome (IBS) Revenue Market Share (2021-2026)
Table 26. Rest of World Based Irritable Bowel Syndrome (IBS) Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Irritable Bowel Syndrome (IBS) Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Irritable Bowel Syndrome (IBS) Revenue Market Share (2021-2026)
Table 29. World Irritable Bowel Syndrome (IBS) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Irritable Bowel Syndrome (IBS) Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Irritable Bowel Syndrome (IBS) Market Size by Type (2027-2032) & (USD Million)
Table 32. World Irritable Bowel Syndrome (IBS) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026) & (USD Million)
Table 34. World Irritable Bowel Syndrome (IBS) Market Size by Application (2027-2032) & (USD Million)
Table 35. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 36. Bausch Health Major Business
Table 37. Bausch Health Irritable Bowel Syndrome (IBS) Product and Services
Table 38. Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Bausch Health Recent Developments/Updates
Table 40. Bausch Health Competitive Strengths & Weaknesses
Table 41. Allergan Basic Information, Manufacturing Base and Competitors
Table 42. Allergan Major Business
Table 43. Allergan Irritable Bowel Syndrome (IBS) Product and Services
Table 44. Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Allergan Recent Developments/Updates
Table 46. Allergan Competitive Strengths & Weaknesses
Table 47. Takeda Basic Information, Manufacturing Base and Competitors
Table 48. Takeda Major Business
Table 49. Takeda Irritable Bowel Syndrome (IBS) Product and Services
Table 50. Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Takeda Recent Developments/Updates
Table 52. Takeda Competitive Strengths & Weaknesses
Table 53. Sucampo Pharmaceuticals (Mallinckrodt) Basic Information, Manufacturing Base and Competitors
Table 54. Sucampo Pharmaceuticals (Mallinckrodt) Major Business
Table 55. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product and Services
Table 56. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments/Updates
Table 58. Sucampo Pharmaceuticals (Mallinckrodt) Competitive Strengths & Weaknesses
Table 59. Sebela Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 60. Sebela Pharmaceuticals Inc Major Business
Table 61. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product and Services
Table 62. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Sebela Pharmaceuticals Inc Recent Developments/Updates
Table 64. Sebela Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 65. Astellas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 66. Astellas Pharmaceuticals Major Business
Table 67. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Services
Table 68. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Astellas Pharmaceuticals Recent Developments/Updates
Table 70. Astellas Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. Global Key Players of Irritable Bowel Syndrome (IBS) Upstream (Raw Materials)
Table 72. Global Irritable Bowel Syndrome (IBS) Typical Customers
LIST OF FIGURES
Figure 1. Irritable Bowel Syndrome (IBS) Picture
Figure 2. World Irritable Bowel Syndrome (IBS) Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Irritable Bowel Syndrome (IBS) Total Revenue (2021-2032) & (USD Million)
Figure 4. World Irritable Bowel Syndrome (IBS) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 13. Irritable Bowel Syndrome (IBS) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 16. World Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 18. China Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 23. India Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Irritable Bowel Syndrome (IBS) by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Irritable Bowel Syndrome (IBS) Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Irritable Bowel Syndrome (IBS) Markets in 2025
Figure 27. United States VS China: Irritable Bowel Syndrome (IBS) Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Irritable Bowel Syndrome (IBS) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Irritable Bowel Syndrome (IBS) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2025
Figure 31. IBS-D Drug
Figure 32. IBS-C Drug
Figure 33. Others
Figure 34. World Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2021-2032)
Figure 35. World Irritable Bowel Syndrome (IBS) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2025
Figure 37. Women
Figure 38. Men
Figure 39. World Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2021-2032)
Figure 40. Irritable Bowel Syndrome (IBS) Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Irritable Bowel Syndrome (IBS) Picture
Figure 2. World Irritable Bowel Syndrome (IBS) Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Irritable Bowel Syndrome (IBS) Total Revenue (2021-2032) & (USD Million)
Figure 4. World Irritable Bowel Syndrome (IBS) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Irritable Bowel Syndrome (IBS) Revenue (2021-2032) & (USD Million)
Figure 13. Irritable Bowel Syndrome (IBS) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 16. World Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 18. China Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 23. India Irritable Bowel Syndrome (IBS) Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Irritable Bowel Syndrome (IBS) by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Irritable Bowel Syndrome (IBS) Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Irritable Bowel Syndrome (IBS) Markets in 2025
Figure 27. United States VS China: Irritable Bowel Syndrome (IBS) Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Irritable Bowel Syndrome (IBS) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Irritable Bowel Syndrome (IBS) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Irritable Bowel Syndrome (IBS) Market Size Market Share by Type in 2025
Figure 31. IBS-D Drug
Figure 32. IBS-C Drug
Figure 33. Others
Figure 34. World Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2021-2032)
Figure 35. World Irritable Bowel Syndrome (IBS) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Irritable Bowel Syndrome (IBS) Market Size Market Share by Application in 2025
Figure 37. Women
Figure 38. Men
Figure 39. World Irritable Bowel Syndrome (IBS) Market Size Market Share by Application (2021-2032)
Figure 40. Irritable Bowel Syndrome (IBS) Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
